Abstract
Introduction
Rett syndrome (RTT, OMIM 312750) is a disorder of postnatal neurodevelopment mainly caused by de novo mutations in the MECP2 gene encoding methyl-CpG binding protein 2 1, 2 .
MECP2 has been involved in up to 90% of classical RTT, however its mutation rate is low (around 20%) in variant RTT 3 . RTT is a clinically defined condition with a large spectrum of phenotype. In the last few years, this genetic disease turned out to be genetically heterogeneous. Microdeletions found by CGH-array as well as balanced translocations allowed the identification of genes responsible for phenotypes that overlap strongly with RTT.
A translocation that disrupted the Netrin G1 gene (NTNG1) was reported in a patient with the early seizure variant of RTT 4 . However mutations in the NTNG1 gene appear to be a very rare cause of RTT as no additional deleterious mutations were published since then. In a diagnostic setting, we have analysed MECP2 2, 13, 14 and CDKL5 genes 9 in a very large cohort of individuals suffering from typical and variant forms of RTT. Here, we report the molecular screening of the FOXG1 gene in a cohort of 35 female individuals with a typical form or a congenital variant of RTT. We described two females heterozygous for a FOXG1 mutated allele.
Patients and methods

Patients
In this study we included 35 female individuals who were recruited at different clinical genetic centres through France with a clinical diagnosis of RTT based on revised criteria for this disorder 15 . All individuals with classical RTT presented with at least seven necessary criteria together with supportive criteria. Thirty one individuals were considered as typical RTT and 4 as congenital or early-onset RTT when the normal perinatal period was absent or shorter than 6 months without any regression period respectively. Mutations in the MECP2 and the CDKL5 genes could not be detected in these patients by direct sequencing of the entire coding sequences and exon/intron boundaries and by multiplex ligation-dependent PCR amplification (MLPA). Blood samples were obtained from patients after informed consent.
Total genomic DNA was extracted from peripheral blood using the Nucleon TM BACC genomic DNA extraction kit (GE Healthcare).
Mutation screening of FOXG1 by direct sequencing of PCR products
We analysed the entire coding sequence by direct sequencing of PCR products. Exons 1 to 5 of the FOXG1 gene were PCR amplified (table I) . Primers were modified by the addition of either M13F (5'-tgtaaaacgacggccagt-3') or M13R (5'-caggaaacagtcatgacc) sequences at their 5' end. The coding sequence was screened by direct DNA sequencing with M13F and M13R primers as described earlier 13 except for exon 4 for which we used internal primers because of a polyT tract at the end of intron 3 ( 
RT-PCR of the FOXG1 transcripts
Total RNAs from whole blood were extracted with the PAXgene TM blood RNA system Table I Results
Identification of mutations in the FOXG1 gene
This molecular study resulted in the finding of premature stop codons (PTCs) at amino acids 308 (c.924A>G; Figure 1A ) and 400 (c.1200C>G; Figure 1C ) in patients 1 and 2 respectively.
Testing of parents revealed that both mutated alleles were de novo. It was not possible to evaluate the effect of the PTCs on the stability of the FOXG1 mRNAs as we failed to RT-PCR amplify any transcripts for this gene in leucocytes and in lymphoblastoïd cells.
Clinical reports
Patient 1 is a girl aged 22, she is the unique child of healthy and unrelated parents. She was born by spontaneous delivery after an uneventful pregnancy with Apgar scores of 8 at 1 min and 10 at 5 min. Birth weight (3,400 g), length (54 cm) and head-circumference (34 cm) were normal. Head growth deceleration was noted at two months. She was considered to be a normal child until the age of 4 months when she presented with strabismus, feeding difficulties and interaction dysfunction. She also presented with global hypotonia, foot deformity (equinovarus), choreic movements, sialorrhoea and night screaming fits. Patient 2 is a 10-year-old female who was born by spontaneous delivery after an uneventful pregnancy. She is the first child of healthy and nonconsanguineous parents. Her birth weight was 3,880 g, and her length was 52 cm with a normal head-circumference (34 cm). She was considered to be a normal child until age 6 months, when developmental delay was noticed.
She was not able to walk until the age of 30 months. Postnatal deceleration of head growth started at the age of 9 mo, her head circumference was 48,5 cm (-2 SD) at 10 years of age. At the age of 5 years, the clinician noticed repetitive stereotyped hand movements, absence of speech, frequent and inappropriate episodes of laughing, and hemihypotrophy of the left half of the body. A normal methylation pattern at the 15q11-q12 region was not in favour of Angelman syndrome and a diagnosis of Rett syndrome was proposed. At the age of 9 years, she presented with autistic behaviour with poor eye contact, ataxia and abundant drooling in addition to self-abusive behaviour. She was capable of saying a few words (mummy and daddy), and bit her hands. Hand stereotypies were not noted anymore and hand skills were improved. Breathing, sleeping pattern and peripheral vasomotor function were normal.
Seizure was never noted by the parents. In addition, she has foot deformity (equinovarus) and minor anomalies with protruding ears, anteverted nostrils and an open mouth appearance.
Brain MRI did not reveal any malformation.
Discussion
FOXG1 located in 14q12 was cloned as a gene containing the fork head domain (HFK1 for Human Fork Head 1) in 1994 17 , it encodes a developmental transcription factor with repressor activities. Its expression profile is restricted to brain and testis. In the mouse, Foxg1 transcription factor is critical for forebrain development. In concert with Fgf (fibroblast growth factor) signalling it participates to early telencephalon patterning at approximately E8.5 in mouse, and is absolutely required for the establishment of ventral identity in the telencephalon 12 . The Foxg1 transcription factor was also implicated in the development of the olfactory system 18 and in sex hormone signalling by interacting with the androgen receptor (AR) protein 19 . FOXG1 is subject to alternative splicing with the FOXG1B major transcript expressed in foetal and adult brain 16, 17 . Four additional FOXG1B splicing variants were recently characterized exclusively in foetal brain tissue 16 .
We report on two nonsense mutations in the can be considered as classical RTT (Table II) according to the revised diagnostic criteria for classical and variant RTT 15 .
The FOXG1B transcript described by the NM_005249 mRNA sequence is encoded by a single exon. We can speculate that the abnormal FOXG1B mRNAs in patients 1 and 2 are not Before our study, to the best of our knowledge a total of 15 FOXG1 alterations were described including 12 large deletions, one t(2;14)(p22;q12) with a breakpoint in intron 3 of FOXG1, and 2 nonsenses (Figure 3) . Initially, chromosome abnormalities revealed by conventional karyotyping or CGH were reported to affect the FOXG1 locus. Seven large deletions of the 14q proximal region encompassing the FOXG1 locus were not precisely mapped [20] [21] [22] [23] [24] . In these cases, the absence of precise breakpoint mapping and the high number of genes in the deleted does not necessarily result in brain malformations in males and in females (Table II, 25, 29 ).
To date, 4 point mutations in FOXG1 have been found in females initially diagnosed as having a typical RTT, a congenital RTT or a severe RTT-like neurodevelopment disorder.
They are associated with a severe phenotype with brain MRI anomalies when the truncated FoxG1 transcription factor is devoid of co-repressors recruiting domains (Table II) . Clinical heterogeneity resulting from allelic heterogeneity is frequent in genetic conditions. We report a late-truncating nonsense associated with a classical RTT. This finding highlights the need to analyse the FOXG1 gene not only in congenital RTT with brain anomalies. Missense mutations in FoxG1 functional domains might result in milder phenotypes including typical and atypical RTT, syndromic mental retardations with telencephalon abnormalities, and nonsyndromic mental retardations. FOXG1 mutation screening should be considered in males with a neurological disorder. The FoxG1 protein interacts with the androgen receptor and may regulate sex-hormone signalling 19 . Abnormal testis development was noticed in two males with an interstitial 14q12 deletion encompassing FOXG1 20, 26 . Therefore, males with brain anomalies, acquired microcephaly, clinical features of the RTT series and testis anomalies would be good candidates for FOXG1 mutation screening.
We applied a two step strategy for the search of point mutations and large rearrangements affecting exons 1 to 5 of FOXG1. A balanced de novo t(2,14) with a 720 kb inversion in Large deletions that were not precisely mapped by means of molecular analysis were not included. 
